Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

31,856 public trials 5,690 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT06051617

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center - 350 W. Thomas Phoenix, Arizona, United States
  • OM Research LLC Lancaster, California, United States
  • SCPMG/Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
View all 211 locations
View Trial Details
Recruiting

International Wilson's Disease Patient Registry (iWilson Registry)

NCT05239858

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • University Hospital Leuven Leuven, Belgium
  • Hospices Civils de Lyon Bron, Auvergne-Rhône-Alpes, France
  • HF Adolphe de Rothschild Paris, Île-de-France Region, France
  • Charite-Univeritatsmedizin Berlin Hospital Berlin, Germany
View all 16 locations
View Trial Details
Recruiting

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

NCT06880523

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View all 13 locations
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05706129

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View Trial Details
Recruiting

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

NCT07555483

Conditions
Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • GC2501 Study Site 106 Birmingham, Alabama, United States
  • GC2501 Study Site 102 Phoenix, Arizona, United States
  • GC2501 Study Site 107 Scottsdale, Arizona, United States
  • GC2501 Study Site 100 Los Angelas, California, United States
View all 22 locations
View Trial Details

Related conditions